---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-015773"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2025-09-26T23:59:59+00:00"
generated_at: "2026-05-17T05:36:21.468577+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma dismisses auditor Bush, appoints Turner Stone; gets $1M funding tranche

## Summary
- Dismissed Bush & Associates CPA as independent auditor effective Sept 22, 2025; 2024 audit included going concern explanatory paragraph.
- Appointed Turner Stone & Co. as new independent auditor for FY 2025, effective Sept 22, 2025.
- No disagreements with Bush; material weaknesses in internal control over financial reporting were disclosed.
- Received $1M second tranche funding under Securities Purchase Agreement for notes with aggregate principal $9.6875M.

## SEC filing metadata
- accession: 0001493152-25-015773
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2025-09-26T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 4.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315225015773/0001493152-25-015773-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315225015773/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-015773
- JSON: https://secwatch.observer/filing/0001493152-25-015773.json
- Plain text: https://secwatch.observer/filing/0001493152-25-015773.txt

## Key facts
- Auditor Changes
  Aspire Biopharma Holdings, Inc. dismissed Bush & Associates CPA as its auditor.
  - Action: dismissal
  - Auditor: Bush & Associates CPA
  - Successor: Turner Stone & Co
  source text: .01 Changes in Registrant’s Certifying Accountant (a) Termination of Previous Independent Registered Accounting Firm On September 22, 2025 Bush & Associates CPA ( “Bush” ) was dismissed by the Audit Committee of the Board of Directors of Aspire Biopharma Holdings, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000149315225015773/0001493152-25-015773-index.htm
- Auditor Changes
  Aspire Biopharma Holdings, Inc. engaged Turner Stone & Co as its auditor.
  - Action: engagement
  - Auditor: Turner Stone & Co
  source text: (b) Appointment of New Independent Registered Public Accounting Firm On September 22, 2025, the Company’s Audit Committee approved the engagement of Turner Stone & Co ( “Turner” ) as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000149315225015773/0001493152-25-015773-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.